4.500USD-0.66%Mkt Cap: 217.63M $P/E: —1d ago
LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Re…
Industry Peers
Health Information Services$32.06BUSDP/E 35.0
$13.38BUSDP/E 88.5
$9.62BUSD
$8.27BUSDP/E 37.0
$6.65BUSD
$5.65BUSD
$4.44BUSDP/E 34.6
$3.43BUSDP/E 160.1
$2.24BUSD
$2.14BUSDP/E 106.8
$1.71BUSD
$1.41BUSD
$1.17BUSD
$1.13BUSD
$1.06BUSDP/E 52.0
$874.42MUSDP/E Infinity
$845.49MUSDP/E 43.2
$672.72MUSDP/E 68.1
$637.77MUSD
$581.77MUSDP/E 27.4
$584.81MUSD
$552.27MUSDP/E 13.1
$524.39MUSD
$516.62MUSD
$494.46MUSDP/E 56.3
$460.71MUSDP/E 25.8
$446.52MUSDP/E 25.4
$393.58MUSDP/E 90.5
$368.70MUSDP/E 45.6
$321.33MUSD
$230.81MUSDP/E 14.1
$224.12MUSDP/E 18.2
$182.96MUSD
$156.35MUSDP/E 39.4
$168.48MUSD
$148.67MUSDP/E 29.6
$123.72MUSDP/E Infinity
$124.79MUSDP/E 18.5
$113.48MUSDP/E 25.4
$99.01MUSDP/E 17.9
$86.66MUSD
$65.63MUSDP/E 11.3
$62.29MUSDP/E 22.6
$57.34MUSD
$47.87MUSDP/E 57.6
$49.50MUSD
$40.55MUSDP/E 38.7
$39.14MUSD
$31.93MUSD
$26.93MUSDP/E 26.0
$22.91MUSDP/E 54.8
$20.17MUSD
$18.43MUSD
$12.99MUSD
$13.69MUSD
$12.35MUSD
$11.72MUSD
$9.78MUSDP/E 15.1
$6.67MUSD
$6.50MUSD
$5.63MUSD
$4.88MUSD
$3.78MUSDP/E Infinity
$3.83MUSDP/E 0.0
$3.40MUSD
$2.98MUSD
$2.70MUSD
$2.16MUSDP/E Infinity
$693.4KUSD
$548.9KUSDP/E 0.0
$282.6KUSD
—
CRY
GraniteShares YieldBOOST CRCL ETF—
EYES
Corgi Data & Surveillance ETF—P/E 30.8
—
—
Indicators:|
Key Statistics
Company
Market Cap217.63M $
Enterprise Value189.33M $
Revenue (TTM)193.33M $
Gross Profit166.34M $
Net Income (TTM)14.35M $
Revenue/Share4.186 USD
Last Price4.500 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees347
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)8.74
PEG—
EV/EBITDA-13.24
EV/Revenue0.98
P/S1.13
P/B14.24
EPS (TTM)-0.44
EPS (Forward)0.52
52W Range
2.56019% of range12.72
52W High12.72 USD
52W Low2.560 USD
Profitability
Gross Margin85.72%
Oper. Margin-17.80%
EBITDA Margin-7.40%
Profit Margin7.40%
ROE61.99%
ROA20.39%
Growth
Revenue Growth-1.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF8.28M $
CapEx (TTM)9.52M $
FCF Margin-2.15%
FCF Yield-1.91%
Net Debt-28.31M $
Net Debt/EBITDA1.98
Balance Sheet
Debt/Equity0.27
Current Ratio1.04
Quick Ratio0.89
Book Value/Sh0.3160 USD
Cash/Share0.7130 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateOct 14, 2020
Splits
Last Split1:5
Split DateOct 14, 2020
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)9.875 USD
Upside (mean)+119.4%
Target Range8.000 USD – 15.00 USD
$8.000+119.4% to mean$15.00
# Analysts8
Ownership
Shares Out.48.36M
Float40.08M
Insiders13.91%
Institutions40.73%
Short Interest
Short Ratio6.3d
Short % Float15.82%
Short % Out.13.23%
Shares Short6.40M
Short (prev mo.)5.59M
Technical
SMA 504.600 (-2.2%)
SMA 2004.310 (+4.4%)
Beta1.99
S&P 52W Chg20.25%
Avg Vol (30d)930.45K
Avg Vol (10d)838.86K
Technical Indicators
RSI (14)47.6
MACD0.0058
MACD Signal0.0149
MACD Hist.-0.0091
BB Upper5.096 USD
BB Middle4.569 USD
BB Lower4.041 USD
BB Width23.11%
ATR (14)0.3118 USD
Vol Ratio (20d)0.54x